The PARI eFlow® rapid nebulizer allows particularly fast and more effective nebulization, significantly reducing time for patients with cystic fibrosis. With time savings of more than 50% and quiet operation, it is beneficial for patients with cystic fibrosis.

With the rapid eFlow, drugs approved for inhalation can be delivered deep into the lungs quickly and efficiently. It is suitable for all approved drugs and is available throughout Europe.

It offers global portability and unmatched hygiene reliability.

• Total Performance: 610 mg/min
• MMD (Mean Mass Aerodynamic Diameter): 4.1 µm
• Mass percentage less than 5µm: 69%

• Shorter treatment duration for better quality of life.
• Quiet operation for discreet use.
• Compact, lightweight, and portable.
• Operates on both main power supply and batteries.
• Easy cleaning and disinfection of consumables according to the highest hygiene standards.
• Functional display with information during nebulization.